Lilly (Eli) (LLY)

Investing Cash Flow

-$25.10B

TTM · Period ending: · USD

LLY logo

LLY Investing Cash Flow

Latest reported-$25.10B
LLY TTM Cash from Investing (-$1.06B → -$25.10B)
High-resolution chart · PNG

LLY investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lilly (Eli) Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-25,096,800,000
-11,535,700,000
-10,972,000,000
-10,090,300,000
-11,112,400,000
-11,476,200,000
-9,301,500,000
-10,305,300,000
-9,381,100,000
-7,641,500,000
-7,152,700,000
-5,088,900,000
-2,963,700,000
-3,331,100,000
-3,679,900,000
-3,198,400,000
-2,859,600,000
-2,516,400,000
-2,762,300,000
-3,057,400,000
-2,754,400,000
-2,481,500,000
-2,258,900,000
-1,626,200,000
-1,736,500,000
-1,465,100,000
-8,082,900,000
-8,700,500,000
-8,674,800,000
-5,602,400,000
1,906,000,000
4,217,900,000
2,858,000,000
-2,524,300,000
-3,783,600,000
-6,614,600,000
-5,651,300,000
-4,423,300,000
-3,139,100,000
-1,707,300,000
-1,482,700,000
-279,400,000
26,800,000
-2,405,800,000
-3,485,400,000
-4,136,700,000
-3,909,100,000
-2,962,600,000
-2,256,700,000
-3,039,500,000
-2,072,800,000
-2,502,900,000
-1,691,800,000
-825,400,000
-2,832,800,000
-3,047,100,000
-3,922,700,000
-5,436,000,000
-4,824,400,000
-4,512,100,000
-4,292,300,000
-3,147,900,000
-3,159,800,000
-1,849,600,000
-993,400,000
-137,100,000
142,800,000
-5,069,200,000
-5,065,300,000
-6,007,500,000
-7,268,800,000
-2,866,600,000
-3,593,900,000
-2,906,800,000
-4,328,100,000
-2,609,000,000
-1,741,600,000
-1,675,200,000
608,400,000
-2,055,800,000
-3,099,700,000
-4,211,100,000
-2,215,900,000
1,828,400,000
1,460,700,000
2,084,900,000
-684,800,000
-3,465,100,000
-2,381,500,000
-2,278,700,000
-1,331,500,000
-1,249,300,000
-2,676,300,000
-2,304,500,000
-2,474,400,000
-2,296,600,000
-1,992,700,000
-3,067,100,000
-3,964,800,000
-3,056,400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.